US 8815917
DP2 antagonist and uses thereof
granted A61KA61K31/195A61P
Quick answer
US patent 8815917 (DP2 antagonist and uses thereof) held by Panmira Pharmaceuticals, LLC expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Panmira Pharmaceuticals, LLC
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/195, A61P, A61P11/00, A61P11/02